PRESENTATIONS FROM OCULAR MELANOMA CONFERENCES

Links to conference presentations will be added here when the videos are posted by A Cure in Sight.

Video 1

Medical Presentation:

• Uveal Melanoma: Where We Are and Where We Are Going  (Dr. Marlana Orloff; 45 minutes)

Video 2

Medical Presentations:

• Uniting the OM Community: Keeping Our Eyes on A Cure [Including Latest Information on VISION Patient Registry]  (Dr. Sara Selig; 45 minutes)

• Development of the Ocular Oncology Clinical Nurse Consultant Role: Impact on Patient Care  (Clinical Nurse Peta Holly; 10 minutes)

Video 3

Medical Presentations:

• Determinants of PKC Inhibitor Response in Uveal Melanoma  (Professor Helen Rizos; 15 minutes)

• Drug Discovery and Development in Human Uveal Melanoma  (Associate Professor Fanfan Zhou; 15 minutes) 

• Improving Plaque Brachytherapy for Uveal Melanoma  (Honorary Researcher Jeremy Flanagan; 15 minutes)

• Q&A  (All Video 3 Presenters; 5 minutes)

Video 4

Medical Presentations:

• How Do Optometrists Manage Choroidal Melanocytic Lesions?  (Associate Professor Michelle Madigan; 15 minutes)

• Uveal Melanoma Tumour Biopsy: South Australia Experience  (Dr. David Sia; 10 minutes)

• Uveal Melanomas: South Australia Pathology Experience  (Dr. Amardeep Gilhotra; 10 minutes)

• An Update on Proton Therapy in Australia and Clinical Application  (Associate Professor Peter Gorayski; 20 minutes)

• The Incidence and Mortality of Conjunctival Melanoma in Australia  (Dr. Aaron Beasley; 15 minutes)

• Q&A  (All Video 4 Presenters; 10 minutes)

Video 5

Medical Presentations:

• Locoregional Therapies for Metastatic Uveal Melanoma  (Professor Roger Olofsson Bagge; 30 minutes)

• Genomics and Prognostication in Uveal Melanoma  (Dr. Emine Kilic; 35 minutes)

• Q&A  (All Video 5 Presenters; 15 minutes)

Day 1 Video

Medical Presentations:

• Primary Disease: Intra-Ocular Melanocytic Lesions  (Dr. Ezekiel Weis; 40 minutes)

• Estimation of Metastatic Risk in Uveal Melanoma  (Dr. Hatem Krema; 55 minutes)

• Genomic Testing for Uveal Melanoma  (Castle Biosciences' Katherina Alsina, PhD, 15 minutes)

• Uveal Melanoma Prognostic Tumor Test  (Impact Genetics' Jaime Jessen, Certified Genetic Counselor; 10 minutes)

Day 2 Video

Medical Presentations:

• Metastatic Uveal Melanoma  (Dr. Marcus Butler; 45 minutes) 

Presentations by patients are also included in each day's video.

All presentations are provided together in a 6-hour video by the conference hosts. The time stamp info below shows where you will find the specific presentation within the video.

Medical Presentations:

•  Ocular Melanoma: Biology, Epidemiology, Diagnosis, and Local Treatment  (Dr. Andrew Stacey; 9:40 time stamp; 50 minutes)

•  Proton Therapy for Ocular Melanoma: Continued Innovation  (Dr. Lia Halasz; 1:00:45 time stamp; 35 minutes) 

•  Systemic Therapy Options for Advanced Ocular Melanoma: Past, Present, and Future  (Dr. Evan Hall; 1:38:15 time stamp; 40 minutes)

•  Liver-Directed Therapies for Metastatic Ocular Melanoma  (Dr. Wayne Monsky; 2:17:00 time stamp; 30 minutes)

•  Predicting Metastasis in Uveal Melanoma: A Research Update  (Dr. Alison Skalet; 2:46:30 time stamp; 65 minutes)

•  Managing Fear of Recurrence  (Dr. Julia Brechbiel; 4:31:30 time stamp; 25 minutes)

•  Genetic Testing for Inherited Cancer Risks  (Lauren Facchini, Genetic Counselor; 4:54:30 time stamp; 20 minutes)

Medical Presentations: 

Primary Ocular Melanoma

• Ocular Melanoma Past, Present, and Future  (Dr. William Harbour; 45 minutes)

• Primary Ocular Melanoma 101  (Dr. Basil Williams; 30 minutes)

• Prognostication and Ocular Care After Treatment of Uveal Melanoma  (Dr. Zelia Correa; 30 minutes)

• Q&A About Primary Ocular Melanoma  (Panel of Presenters; 10 minutes)

Metastatic Ocular Melanoma

• Liver-Directed Therapies for Metastatic Uveal Melanoma  (Dr. David Eschelman; 60 minutes)

• High-Risk Uveal Melanoma and Adjuvant Therapies  (Dr. Jose Lutzky; 30 minutes)

• Current Status of Systemic Therapy for Uveal Melanoma  (Dr. Ahmad Tarhini; 20 minutes)

• Current Clinical Trials for Metastatic Uveal Melanoma  (Dr. Nikhil Khushalani; 25 minutes)

• Q&A About Systemic Treatment & Metastatic Disease  (Panel of Presenters; 20 minutes)

Primary and Metastatic

• A Field of Hope: Ocular Melanoma Research Updates and Discussion  (Keiran Smalley, PhD; Dr. Alison Skalet; Florian Karreth, PhD; and David Morse, PhD; 70 minutes)

All videotaped presentations from this conference

OM Diagnosis, Genetics, Treatment, and Research:

• KIMMTRAK Approved: Now What?  (Dr. Meredith McKean and Dr. Justin Moser; 50 minutes)

• Ocular Melanoma Mets Explained  (Dr. Meredith McKean, Dr. Justin Moser, and Dr. Maureen Sanger; 50 minutes)

• Standards of Care in Uveal Melanoma  (Dr. Peter Hovland, Dr. David Reichstein, and Dr. Amy Schefler; 55 minutes)

• What Is the INSIGHT Ocular Melanoma Patient Registry?  (Dr. Armin Afshar; 35 minutes)

• Your Eye After Plaque Brachytherapy Treatment  (Dr. David Reichstein; 55 minutes)

Mental Health and Self-Advocacy:

Links to videotaped conference presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage. 

Low Vision:  

Link to videotaped conference presentation on low-vision tools and techniques can be found on EyeMelanoma.org's Vision-Related Support webpage. 

All videotaped presentations from this conference

Medical Presentations:

• Ocular Melanoma Eye Treatments, Side Effects, and How to Manage Them  (Dr. Rumana Hussain; 35 minutes)

• Liver-Directed Therapies and How They Impact Quality of Life  (Dr. Brian Stedman; 50 minutes)

• Uveal Melanoma UK Guidelines, Update on Systemic Treatments, and Update on Current Trials  (Prof. Tobias Arkenau and Dr. Paul Nathan; 90 minutes)

All videotaped presentations from this conference

Video of Clinical Research Sessions: Part 1

• Primary Ocular Melanoma 101  (Dr. Carol Shield; 51:25 to 1:27:04)

• Post-Primary Treatment  (Dr. Sara Lally; 1:27:04 to 1:51:21)

• Surveillance and Adjuvant Therapy  (Dr. Rino Seedor; 1:51:21 to 2:10:00)

• Past, Present, and Future of Uveal Melanoma  (Dr. Takami Sato; 2:49:00 to 3:19:40)

Video of Clinical Research Sessions: Part 2

• Treatments for Metastatic Disease: Liver Directed Therapies  (Order of presenters: Dr. Rani Anne, Dr. Robert Adamo, and Dr. Carin Gonsalves; 0:00 to 1:08:07) 

• Treatments for Metastatic Disease: Immunotherapies  (Dr. Marlana Orloff; 1:08:07 to 1:34:52)

• Treatments for Metastatic Disease: Molecular Targeted Therapies  (Dr. Rino Seedor; 1:34:52 to 1:51:57)

• Basic Science Updates  (Dr. Andrew Aplin; 1:51:57 to 2:19:07)

• Closing Remarks  (Dr. Sara Selig; 2:19:07 to 2:25:00)

Video 1:

• Current and Emerging Systemic Treatment Choices for Metastatic Uveal Melanoma  (Dr. Paul Nathan; 30 minutes)

Video 2:

• Novel Treatments of Uveal Melanoma  (Prof. Jonas Nilsson; 20 minutes)

• Liver-Directed Therapies for Metastatic Uveal Melanoma  (Dr. David Eschelman; 20 minutes)

Video 3:

• Australian National Uveal Melanoma Treatment Pathway  (Dr. John McKenzie; 20 minutes)

• Ocular Prostheses  (Ocularist Camille Loyer; 15 minutes)

Video 4:

• A Global Survey on Ruthenium Eye Plaque Practice  (Dr. Lotte Fog; 15 minutes)

• Another Option in the Radiotherapy Toolkit: Gantry-Based Proton Therapy  (Dr. Amanda Deisher; 15 minutes)

• Proton Therapy for Uveal Melanoma  (Dr. Sachin Salvi; 20 minutes)

Video 5:

• Pathology of Uveal Melanoma  (Prof. Penny McKelvie; 20 minutes)

• Transretinal Tumour Biopsy Techniques  (Prof. Heinrich Heimann; 15 minutes)

• Uveal Melanoma Biopsy at the Time of Plaque Brachytherapy  (Dr. Rod O'Day; 15 minutes)

Video 6:

• Genetics and Genomics in Uveal Melanoma  (Dr. Peter Johansson; 15 minutes)

• Proteomics in Uveal Melanoma  (Prof. Sarah Coupland; 15 minutes)

• Liquid Biopsies in Uveal Melanoma  (Dr. Aaron Beasley; 15 minutes)

OM Diagnosis, Genetics, Treatment, and Research:

• Ocular Melanoma Advocacy  (Melanoma Research Foundation's Cassie Beisel; 50 minutes)

• Ocular Melanoma Clinical Trials  (Dr. Richard Carvajal, Dr. Marlana Orloff, Dr. Sapna Patel, and Dr. Sara Selig; 75 minutes)

• Upcoming Ocular Melanoma Treatments  (Dr. Richard Carvajal and Dr. Sara Selig; 35 minutes)

• VISION Patient Registry Update  (Dr. Richard Carvajal and Dr. Sara Selig; 60 minutes)

All videotaped presentations from this conference

OM Diagnosis, Genetics, Treatment, and Research: 

• How My Patients Made Me a Better Ocular Oncologist  (Dr. Bertil Damato; 45 minutes)

• Keynote Presentation: What's New in Uveal Melanoma in 2021  (Dr. Prithvi Mruthyunjaya; 45 minutes)

• Making Drug Development Work For Uncommon Cancers  (Dr. Anthony Tolcher; 45 minutes)

• Navigating a Diagnosis of Metastatic Uveal Melanoma  (Dr. Adil Daud and Dr. Justin Moser; 50 minutes)

• Treatment of Advanced Uveal Melanoma  (Dr. Jose Lutzky; 45 minutes)

• Uveal Melanoma Genetics Explained  (Genetic counselor Jaime Jessen and Dr. Basil Williams; 50 minutes)

• What to Expect After Radiation Treatment for Uveal Melanoma: A Patient's Perspective  (Dr. Armin Afshar and Dr. Timothy Murray; 50 minutes)

• What's New in Uveal Melanoma — NCCN Guidelines' Prognostic Information and Standards of Care  (Dr. David Reichstein, Dr. Amy Schefler, and Dr. Andrew Stacey; 50 minutes) 

• Why Should I Join a Registry? About the INSIGHT Ocular Melanoma Patient Registry  (Dr. Armin Afshar and Dr. Bertil Damato; 45 minutes)

Mental Health and Self-Advocacy:

Links to videotaped conference presentations on these two topics can be found on EyeMelanoma.org's Patient Empowerment webpage. 

Low Vision:  

Links to videotaped conference presentations on low-vision tools and techniques can be found on EyeMelanoma.org's Vision-Related Support webpage. 

All videotaped presentations from this conference